A Study to Evaluate the Safety, Tolerability, and Immunogenicity of V114 Followed by PNEUMOVAX™23 in Healthy Adults 50 Years of Age or Older (V114-016/PNEU-PATH)
Public ClinicalTrials.gov record NCT03480763. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
A Phase 3, Multicenter, Randomized, Double-blind, Active Comparator-controlled Study to Evaluate the Safety, Tolerability, and Immunogenicity of V114 Followed by Administration of PNEUMOVAX™23 One Year Later in Healthy Adults 50 Years of Age or Older (PNEU-PATH)
Brief summary
Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.
This study is designed 1) to evaluate the safety, tolerability, and immunogenicity of V114 and Prevnar 13™, 2) to describe the safety of sequential administration of V114 or Prevnar 13™ followed by PNEUMOVAX™23, and 3) to evaluate the immune responses to the 15 serotypes contained in V114 when PNEUMOVAX™23 is given approximately 12 months after receipt of either V114 or Prevnar 13™ in healthy adults 50 years of age or older. There was no formal hypothesis testing.
Study identification
- NCT ID
- NCT03480763
- Recruitment status
- Completed
- Study type
- Interventional
- Phase
- Phase 3
- Enrollment
- 652 participants
Conditions and interventions
Conditions
Eligibility (public fields only)
- Age range
- 50 Years and older
- Sex
- All
- Healthy volunteers
- Accepts healthy volunteers
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Jun 22, 2018 (Actual)
- Primary completion
- Dec 23, 2019 (Actual)
- Completion
- Dec 23, 2019 (Actual)
- Last update posted
- Nov 2, 2021
2018 – 2019
United States locations
- U.S. sites
- 15
- U.S. states
- 9
- U.S. cities
- 15
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| East Valley Family Physicians ( Site 0104) | Chandler | Arizona | 85224 | — |
| Central Phoenix Medical Clinic, LLC ( Site 0125) | Phoenix | Arizona | 85020 | — |
| Encompass Clinical Research ( Site 0118) | Spring Valley | California | 91978 | — |
| Diablo Clinical Research, Inc ( Site 0132) | Walnut Creek | California | 94598 | — |
| Clinical Research of South Florida ( Site 0126) | Coral Gables | Florida | 33134 | — |
| QPS Miami Research Associates ( Site 0116) | South Miami | Florida | 33143 | — |
| Heartland Research Associates, Llc ( Site 0115) | Wichita | Kansas | 67207 | — |
| Centennial Medical Group ( Site 0109) | Elkridge | Maryland | 21075 | — |
| Rapid Medical Research, Inc. ( Site 0119) | Cleveland | Ohio | 44122 | — |
| University of Texas Medical Branch at Galveston ( Site 0127) | Galveston | Texas | 77555-1115 | — |
| Texas Center For Drug Development ( Site 0107) | Houston | Texas | 77081 | — |
| Diagnostics Research Group ( Site 0100) | San Antonio | Texas | 78229 | — |
| J Lewis Research Inc / Foothill Family Clinic ( Site 0123) | Salt Lake City | Utah | 84109 | — |
| J Lewis Research Inc/Jordan River Family Medicine ( Site 0114) | South Jordan | Utah | 84095 | — |
| Health Research of Hampton Roads, Inc. ( Site 0106) | Newport News | Virginia | 23606 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
Non-U.S. locations
This page focuses on the U.S. directory. The official record also lists 7 non-U.S. sites.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT03480763, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Nov 2, 2021 · Synced Oct 17, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete public registry record, listed eligibility criteria, and available contact information for NCT03480763 live on ClinicalTrials.gov.